SB 137: Require hospitals to provide overdose reversal drugs - Ohio

As Passed by the House → As Enrolled · 3 edits · Mar 10, 2026

MINOR

The bill was finalized into its official enrolled form, removing House-specific markings and adding standard signature lines for legislative approval. The core policy requirements regarding hospital provision of overdose reversal drugs remain unchanged from the House version.

Scope change

The bill's scope and applicability are unchanged; it still applies to hospitals in Ohio's 136th General Assembly.

TECHNICAL

Removed 'As Passed by the House' headers and page numbers, replacing them with official enrolled formatting including the 136th General Assembly designation and standard act title.

Added signature lines for the Speaker of the House, President of the Senate, Governor, and Secretary of State to finalize the bill's enactment.

Replaced the informal bill header with the formal 'AN ACT' title and standard statutory language required for final passage.

As Passed by the Senate → As Passed by the House · 2 edits · Feb 25, 2026

MINOR

The bill was amended to add House representatives as cosponsors and reformat the layout. Substantively, the text of the law remains identical, establishing requirements for hospitals to provide overdose reversal drugs to patients with opioid-related symptoms upon discharge.

Scope change

No change in scope; the bill applies to hospitals in the same manner as the Senate version.

TECHNICAL

Cosponsor list was updated to include House representatives, and the document formatting was adjusted to reflect the House's version.

Page breaks and line numbering were reorganized to match the House's pagination style.

As Introduced → As Passed by the Senate · 2 edits · Oct 8, 2025

MINOR

The bill was amended to update the name of the state mental health agency to the 'department of behavioral health' and added a new section requiring hospitals to submit aggregated reports on overdose reversal drug distribution. These changes ensure the legislation aligns with current state agency names and establish a formal data collection process to track drug usage without revealing patient identities.

Scope change

The bill's scope regarding agency oversight was updated to reflect the current name of the state department responsible for behavioral health services.

DEFINITION

Updated references to the 'department of mental health and addiction services' to the 'department of behavioral health' throughout the text to match current state agency nomenclature.

REQUIREMENT

Added a new requirement for hospitals to prepare and submit reports to both the department of health and the department of behavioral health regarding the distribution of overdose reversal drugs, ensuring data is collected while maintaining patient anonymity.

Require hospitals to provide overdose reversal drugs

What changed between versions

How they voted

Actions timeline

Sponsors